Biomedical Applications of Biogenic Zinc Oxide Nanoparticles Manufactured from Leaf Extracts of Calotropis gigantea (L.) Dryand.

Abstract

Green synthesis has made us an exciting approach in the field of nanotechnology. Biogenic zinc oxide nanoparticles (ZnONPs) were synthesized using leaf extracts of Calotropis gigantea (L.) Dryand. in the presence of zinc nitrate hexahydrate as a precursor molecule. ZnONPs were characterized using scanning electron microscope (SEM), X-ray diffraction (XRD) patterns, and Fourier transform infrared spectroscopy (FT-IR) analysis and further in understanding the biomedical applications of antimicrobial (minimum inhibitory concentration method) and anticancer (apoptosis assay) activities, cytology (flow cytometry) and cytotoxicity (% cell viability), deoxyribonucleic acid (DNA) fragmentation (reverse transcriptase polymerase chain reaction (RT-PCR)), and caspase assay (polymerase chain reactions (PCR)) studies. The morphology of nanoparticles was determined by SEM analysis. XRD pattern showed the value of highest peak of 36.15° with 101 plane region among the ten recorded peaks. FTIR spectrum indicated stretching vibration of O-H at 3441.77 cm−1. The antibacterial activity of biogenic ZnO nanoparticles was studied against human pathogenic bacteria—Campylobacter jejuni ATCC 29428 and Neisseria gonorrhoeae ATCC 49226—and showed 50% zone of inhibition. A cytotoxic study against the breast cancer cell lines of MDAMB-231 revealed that the ZnONPs as a good anticancer agent could be sliced by all existing and metabolically active cells. Biosynthesized ZnONPs potentially alter the apoptotic protein expression and trigger apoptosis in the MDAMB-231 cells. Therefore, the biogenic ZnO nanoparticles would be useful and have the great potential in the field of biomedical applications.